Viewing Study NCT06462417



Ignite Creation Date: 2024-07-17 @ 10:47 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06462417
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-18
First Post: 2024-06-12

Brief Title: Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis
Sponsor: Zheng Liu
Organization: Huazhong University of Science and Technology

Study Overview

Official Title: Study on the Efficacy and Safety of Oral Administration of Arbidol in the Treatment of Allergic Rhinitis Patients
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The most important treatment for AR is topical nasal medications including nasal corticosteroids nasal antihistamines nasal decongestants and nasal saline irrigation etc which are still limited Arbidol may inhibit molecular targets involved in the pathogenesis of AR This study intends to explore the effect of Arbidol in the treatment of allergic rhinitis and evaluate its efficacy and safety
Detailed Description: Allergic rhinitis AR is a non-infectious inflammatory disease of the nasal mucosa mediated by Immunoglobulin E after exposure to allergens AR has become a major chronic inflammatory disease of the respiratory tract which has a serious impact on the quality of life of patients and social economy The most important treatment for AR is topical nasal medications including nasal corticosteroids nasal antihistamines nasal decongestants and nasal saline irrigation etc However even if patients are treated completely according to the standard diagnosis and treatment strategy a considerable number of patients still do not achieve satisfactory treatment results Arbidol is a medicine for the prevention and treatment of influenza Based on our previous laboratory data Arbidol may inhibit molecular targets involved in the pathogenesis of AR In order to make the treatment of AR more effective timely and convenient this study intends to explore the effect of Arbidol in the treatment of allergic rhinitis and evaluate its efficacy and safety

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None